4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Yarrow Bioscience Inc (YARW) operates in the Biotechnology industry and is headquartered in New York, United States with about 7 employees. Its market capitalization is roughly $81 million.
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.
Interactive charts & full statements →
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($3M) | ($3M) | ($1M) | ($8M) |
| Net Income | ($3M) | ($3M) | ($71M) | ($6M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 |
|---|---|
| Total Assets | $100M |
| Total Liabilities | $72M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive YARW viewer.
About TickerBase · Data methodology & sources · Privacy · Terms